Xin-bao Li - Publications

Analysis on the efficacy and safety of chemotherapy combined with or without bevacizumab after CRS+HIPEC in patients with malignant peritoneal mesothelioma: a single-center retrospective study.

Journal: Frontiers in oncology

Published: October 28, 2025

Efficacy of postoperative immunotherapy on MPM patients after CRS + HIPEC: A single-center retrospective study based on propensity score matching.

Journal: International journal of cancer

Published: January 18, 2025

Effect of postoperative normothermic intraperitoneal chemotherapy on the prognosis of MPM patients receiving CRS+HIPEC: A single-center case-control study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: July 28, 2024

Prognostic Factors of Long-Term Survival and Conditional Survival Analysis in MPM Patients Treated with CRS+HIPEC: A Retrospective Study of Two Centers.

Journal: Annals of surgical oncology

Published: July 26, 2024

Research progress of malignant peritoneal mesothelioma with paraneoplastic syndrome: A review.

Journal: Journal of surgical oncology

Published: February 16, 2024

Risk factors and prognosis of malignant peritoneal mesothelioma with paraneoplastic syndrome.

Journal: World journal of surgical oncology

Published: October 20, 2023

Long-term survival in patients with PMP: a single-institutional retrospective study from China.

Journal: World journal of surgical oncology

Published: August 01, 2023

Outcomes Following Cytoreductive Surgery and Hyperthermic Intraoperative Thoraco-Abdominal Chemotherapy with Diaphragm Resection for Peritoneal Carcinomatosis: A Retrospective Cohort Study.

Journal: Annals of surgical oncology

Published: July 28, 2023

Effect of standardized fluid management on cardiac function after CRS + HIPEC in patients with PMP: a single-center case-control study.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: March 08, 2023

Whole-Exome Sequencing Identifies Mutation Profile and Mutation Signature-Based Clustering Associated with Prognosis in Appendiceal Pseudomyxoma Peritonei.

Journal: Molecular cancer research : MCR

Published: October 11, 2022

Key factors for successful cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat diffuse malignant peritoneal mesothelioma: results from specialized peritoneal cancer center in China.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: April 29, 2022

Tumor-stroma ratio as a new prognosticator for pseudomyxoma peritonei: a comprehensive clinicopathological and immunohistochemical study.

Journal: Diagnostic pathology

Published: September 15, 2021